Discovery of orally active vitronectin receptor (αvβ3) antagonists.

被引:0
|
作者
Heerding, DA
Miller, WH
Willette, R
Yue, TL
Lark, M
Stroup, G
Badger, A
Ohlstein, E
Gowen, M
Huffman, WF
机构
[1] SmithKline Beecham Pharmaceut, Med Chem, Collegeville, PA 19426 USA
[2] SmithKline Beecham Pharmaceut, Cardiovasc Biol, Collegeville, PA USA
[3] SmithKline Beecham Pharmaceut, Bone & Cartilage Biol, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
175-MEDI
引用
收藏
页码:U567 / U568
页数:2
相关论文
共 50 条
  • [21] 2-benzylcarbonylthiophene-3-sulfonamides are orally active ET(A) selective endothelin antagonists.
    Wu, CD
    Raju, B
    Okun, I
    Stavros, F
    Chan, MF
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 148 - MEDI
  • [22] Discovery of potent and selective isoxazoline antagonists of the vitronectin receptor
    Pitts, WJ
    Wityak, J
    Jetter, J
    Harlow, PP
    Corjay, MH
    Mousa, SA
    Wexler, RR
    Jadhav, PK
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U886 - U886
  • [23] Nonpeptide αvβ3 antagonists.: Part 11:: Discovery and preclinical evaluation of potent αvβ3 antagonists for the prevention and treatment of osteoporosis
    Coleman, PJ
    Brashear, KM
    Askew, BC
    Hutchinson, JH
    McVean, CA
    Duong, LT
    Feuston, BP
    Fernandez-Metzler, C
    Gentile, MA
    Hartman, GD
    Kimmel, DB
    Leu, CT
    Lipfert, L
    Merkle, K
    Pennypacker, B
    Prueksaritanont, T
    Rodan, GA
    Wesolowski, GA
    Rodan, SB
    Duggan, ME
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (20) : 4829 - 4837
  • [24] Discovery of orally active nonpeptide bradykinin B2 receptor antagonists
    Asano, M
    Inamura, N
    Hatori, C
    Sawai, H
    Fujiwara, T
    Abe, Y
    Kayakiri, H
    Satoh, S
    Oku, T
    Nakahara, K
    [J]. IMMUNOPHARMACOLOGY, 1999, 43 (2-3): : 163 - 168
  • [25] Discovery of a novel class of orally active CGRP receptor antagonists for the treatment of migraine
    Bell, Ian
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [26] Discovery of novel orally active ureido NPYY5 receptor antagonists
    Li, Guoqing
    Stamford, Andrew W.
    Huang, Ying
    Cheng, Kuo-Chi
    Cook, John
    Farley, Constance
    Gao, Jun
    Ghibaudi, Lorraine
    Greenlee, William J.
    Guzzi, Mario
    van Heek, Margaret
    Hwa, Joyce J.
    Kelly, Joe
    Mullins, Deborra
    Parker, Eric M.
    Wainhaus, Sam
    Zhang, Xiaoping
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 1146 - 1150
  • [27] Discovery of new orally active prostaglandin D2 receptor antagonists
    Iwahashi, Maki
    Naganawa, Atsushi
    Kinoshita, Atsushi
    Shimabukuro, Atsushi
    Nishiyama, Toshihiko
    Ogawa, Seiji
    Matsunaga, Yoko
    Tsukamoto, Kohki
    Okada, Yutaka
    Matsumoto, Ryoji
    Nambu, Fumio
    Oumi, Rie
    Odagaki, Yoshihiko
    Katagi, Jun
    Yano, Koji
    Tani, Kousuke
    Nakai, Hisao
    Toda, Masaaki
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) : 6935 - 6948
  • [28] Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists
    Sinz, Christopher
    Chang, Jiang
    Lins, Ashley Rouse
    Brady, Ed
    Candelore, Mari
    Dallas-Yang, Qing
    Ding, Victor
    Jiang, Guoqiang
    Lin, Zhen
    Mock, Steven
    Qureshi, Sajjad
    Salituro, Gino
    Saperstein, Richard
    Shang, Jackie
    Szalkowski, Deborah
    Tota, Laurie
    Vincent, Stella
    Wright, Michael
    Xu, Shiyao
    Yang, Xiaodong
    Zhang, Bei
    Tata, James
    Kim, Ronald
    Parmee, Emma
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 7131 - 7136
  • [29] Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists
    Hasegawa, Futoshi
    Niidome, Kazumi
    Migihashi, Chiaki
    Murata, Makoto
    Negoro, Toshiyuki
    Matsumoto, Takafumi
    Kato, Kaori
    Fujii, Akihito
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (17) : 4266 - 4270
  • [30] Synthesis and biological evaluation of potent isonipecotamide-based vitronectin receptor antagonists.
    Ghosh, S
    Andrade-Gordon, P
    Costanzo, M
    De Corte, B
    Hoekstra, WJ
    Kinney, WA
    Luci, DK
    Liu, L
    Maryanoff, BE
    Santulli, R
    Yabut, SC
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U22 - U22